These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27920141)

  • 21. Prostate cancer: treatment-specific nomograms, biochemical recurrence, and prostate cancer-specific mortality.
    Phillips R
    Nat Rev Urol; 2014 Dec; 11(12):657. PubMed ID: 25330792
    [No Abstract]   [Full Text] [Related]  

  • 22. Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases.
    Heidenreich A; Fossati N; Pfister D; Suardi N; Montorsi F; Shariat S; Grubmüller B; Gandaglia G; Briganti A; Karnes RJ
    Eur Urol Oncol; 2018 May; 1(1):46-53. PubMed ID: 31100228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer.
    Kishan AU; Tendulkar RD; Tran PT; Parker CC; Nguyen PL; Stephenson AJ; Carrie C
    Eur Urol Oncol; 2018 May; 1(1):3-18. PubMed ID: 31100226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radical prostatectomy versus watchful waiting for prostate cancer.
    Hegarty J; Beirne PV; Walsh E; Comber H; Fitzgerald T; Wallace Kazer M
    Cochrane Database Syst Rev; 2010 Nov; (11):CD006590. PubMed ID: 21069689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance-Does Cancer Vanish or Simply Hide?
    Chu CE; Cowan JE; Fasulo V; Washington SL; de la Calle C; Shoemaker J; Carroll PR
    J Urol; 2021 Jan; 205(1):109-114. PubMed ID: 33198555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active Surveillance.
    Godtman RA; Schafferer M; Pihl CG; Stranne J; Hugosson J
    J Urol; 2018 Oct; 200(4):779-785. PubMed ID: 29730198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?
    Carlsson SV; Månsson M; Moss S; Kwiatkowski M; Recker F; Tammela TLJ; Bangma C; Roobol MJ; Auvinen A; Hugosson J
    Eur Urol; 2019 Jun; 75(6):1015-1022. PubMed ID: 30928162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial.
    Bill-Axelson A; Holmberg L; Filén F; Ruutu M; Garmo H; Busch C; Nordling S; Häggman M; Andersson SO; Bratell S; Spångberg A; Palmgren J; Adami HO; Johansson JE;
    J Natl Cancer Inst; 2008 Aug; 100(16):1144-54. PubMed ID: 18695132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Active Surveillance for Men with Intermediate Risk Prostate Cancer.
    Agrawal V; Ma X; Hu JC; Barbieri CE; Nagar H
    J Urol; 2021 Jan; 205(1):115-121. PubMed ID: 32658588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PSA nadir and outcome in 100 patients with pT3b prostate cancer.
    Pepe P; Improta G; Fraggetta F; Emmanuele C; Simeon V; Dibenedetto G; Colecchia M; Aragona F
    Anticancer Res; 2014 Feb; 34(2):937-41. PubMed ID: 24511036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate cancer: surgery versus observation for localized prostate cancer.
    van den Bergh RC; Giannarini G
    Nat Rev Urol; 2014 Jun; 11(6):312-3. PubMed ID: 24818851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of Active Surveillance and Watchful Waiting for localized prostate cancer in the daily practice.
    Herden J; Weissbach L
    World J Urol; 2018 Mar; 36(3):383-391. PubMed ID: 29330583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer.
    Maggi M; Cowan JE; Fasulo V; Washington SL; Lonergan PE; Sciarra A; Nguyen HG; Carroll PR
    J Urol; 2020 Dec; 204(6):1222-1228. PubMed ID: 33157570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Editorial comment on: tumor grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancer.
    Yossepowitch O
    Eur Urol; 2010 Apr; 57(4):639-40. PubMed ID: 19299071
    [No Abstract]   [Full Text] [Related]  

  • 35. Editorial comment on: tumour grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancer.
    Gallina A
    Eur Urol; 2010 Apr; 57(4):639. PubMed ID: 19299073
    [No Abstract]   [Full Text] [Related]  

  • 36. Survival following biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in patients with prostate cancer: the impact of competing causes of mortality and patient stratification.
    Abdollah F; Boorjian S; Cozzarini C; Suardi N; Sun M; Fiorino C; di Muzio N; Karakiewicz PI; Montorsi F; Karnes RJ; Briganti A
    Eur Urol; 2013 Oct; 64(4):557-64. PubMed ID: 23506833
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Maurer T; Robu S; Schottelius M; Schwamborn K; Rauscher I; van den Berg NS; van Leeuwen FWB; Haller B; Horn T; Heck MM; Gschwend JE; Schwaiger M; Wester HJ; Eiber M
    Eur Urol; 2019 Apr; 75(4):659-666. PubMed ID: 29625755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.
    Abdollah F; Schmitges J; Sun M; Jeldres C; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    Int J Urol; 2012 Sep; 19(9):836-44. PubMed ID: 22574746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation therapy after radical prostatectomy.
    Ziada AM; Crawford ED
    ScientificWorldJournal; 2004 Jun; 4 Suppl 1():377-81. PubMed ID: 15349561
    [No Abstract]   [Full Text] [Related]  

  • 40. Radical prostatectomy versus radiation therapy: can pretreatment nomograms be used to select the appropriate prostate cancer treatment?
    Simon RM; Salama JK; Freedland SJ
    Eur Urol; 2015 Feb; 67(2):210-1. PubMed ID: 25457494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.